SCHEMBL31057453

SCHEMBL31057453

CON(C)C(=O)c1nn2c(c1C)CN(C(=O)OC(C)(C)C)CCC2

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ GPR119 Q8TDV5 4/20 0.37
▸ NR1H2 P55055 2/20 0.35
▸ PREP P48147 1/20 0.35
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ CYBB P04839 1/20 0.34
▸ NOX5 Q96PH1 1/20 0.34
▸ NOX4 Q9NPH5 1/20 0.34
▸ NOX1 Q9Y5S8 1/20 0.34
▸ HPGD P15428 1/20 0.33
▸ ESR2 Q92731 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ USP2 O75604 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ F12 P00748 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24535150 0.90 GPR119 (0.36) GPR119NR1H2PREPMEN1KMT2A
SCHEMBL26686767 0.88 MEN1 (0.38) GPR119NR1H2PREPMEN1KMT2A
SCHEMBL30793376 0.85 USP30 (0.39) GPR119PREPHPGD
SCHEMBL25338426 0.84 NR1H2 (0.43) NR1H2PREPMEN1KMT2ACYBB
SCHEMBL25336741 0.84 MEN1 (0.38) GPR119NR1H2PREPMEN1KMT2A
SCHEMBL30752551 0.83 GPR119 (0.37) GPR119NR1H2PREPESR2MAPT
SCHEMBL25337124 0.81 KMT2A (0.36) NR1H2PREPMEN1KMT2ACYBB
SCHEMBL30793753 0.80 MEN1 (0.37) NR1H2PREPMEN1KMT2ACYBB
SCHEMBL30793809 0.79 MEN1 (0.36) GPR119NR1H2PREPMEN1KMT2A
SCHEMBL30793502 0.78 GPR119 (0.38) GPR119NR1H2PREPMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4665735-A1 KRAS INHIBITORS Erasca, Inc. (US) 2025-12-24 — — EP disclosed
WO-2025245105-A1 KRAS INHIBITORS ERASCA, INC. (US) 2025-11-27 — — WO disclosed
WO-2024173842-A1 KRAS INHIBITORS ERASCA, INC. (US) 2024-08-22 — — WO disclosed
Send feedback